LPCN
Lipocine·NASDAQ
--
--(--)
--
--(--)
5.40 / 10
Netural
Capital flow assessment yields 7.56/10, denoting robust fund flow characteristics. Strengths in no significant trends trends confront pressures from overall, block, Small, Medium, Large, and Extra-large patterns, resulting in positive liquidity outlook. Professional analyst opinion suggests overwhelmingly bullish analyst consensus, showing strong conviction. Distribution pattern: Strong Buy(100.0%) based on 1 research evaluations, supported by 3.24 historical weighted rating.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Yi ChenStrong Buy
Date2026-01-21
InstitutionHC Wainwright & Co.
Times predicted6
Historical Win Rate16.7%
What is the analyst consensus for LPCN?
- LPCN holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 5.40/10 (Netural).
